This case report bespeaks the value of both thorough clinical assessment and targeted genetic screening in the prompt diagnosis of rare disorders.
Introduction
Hyperostosis-hyperphosphataemia syndrome (HHS) is a rare autosomal recessive condition caused by inactivating mutations in the GALNT3 gene, characterised by elevated serum phosphate and 1,25(OH) 2 
Case report
 A 15 year old boy (weight +1.05 SD; height -0.1 SD) with consanguineous parents of Palestinian descent, presented with a 6 year history of recurrent episodes of flitting pain in his forearms and lower legs.  Episodes typically lasted 1-4 weeks were associated with erythema of the overlying skin, swelling of the underlying tissue with no obvious triggers.  Previous investigations had included a biopsy of the ulna which revealed only non-specific findings (ossified material surrounding calcified cartilaginous tissue).  Diagnoses of osteopetrosis and chronic recurrent multifocal osteomyelitis (CRMO) had been made in the past.  Treatment with intermittent glucocorticoids and NSAIDS had produced symptomatic benefit.  General examination was unremarkable apart from thickening and widening of the right ulnar border and anterior border of the right tibia. 
Discussion
This case report illustrates the characteristic clinical, biochemical and radiological features of HHS along with the potential for misdiagnosis. Judicious use of NSAIDS and steroids may be helpful. Surgical decompression has been described for patients with severe pain not amenable to analgesics. Long term monitoring of blood pressure and cardiovascular health would seem prudent.
Diagnosis
The clinical, biochemical and radiological findings are all consistent with the rare diagnosis of HHS. Mutation analysis of the GALNT3 gene revealed a homozygous GALNT3 frame shift mutation (c.803dupC), confirming the clinical diagnosis of Hyperostosis-hyperphosphataemia syndrome.
